Form 8-K - Current report:
SEC Accession No. 0000950123-02-000138
Filing Date
2002-01-07
Accepted
2002-01-07 00:00:00
Documents
6
Period of Report
2001-12-21
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS INC. y56066e8-k.txt 8-K 19883
3 ASSET PURCHASE AGREEMENT y56066ex2-1.txt EX-2.1 107354
4 NON-QUALIFIED STOCK OPTION PLAN y56066ex2-2.txt EX-2.2 22108
5 INVESTOR RIGHTS AGREEMENT y56066ex4-1.txt EX-4.1 46759
6 MANUFACTURING AGREEMENT y56066ex10-1.txt EX-10.1 191986
7 PRESS RELEASE y56066ex99-1.txt EX-99.1 5210
  Complete submission text file 0000950123-02-000138.txt   395612
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 2503168
SIC: 2835 In Vitro & In Vivo Diagnostic Substances